[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Administrative Procedures for Clinical Labo...[ Price : $8.95]
FDA approves a Melinta Therapeutics supplemental NDA for Baxdela (delafloxacin) for treating adult patients with community-acquire...[ Price : $8.95]
FDA authorizes NuCana to begin a Phase 3 study (nutide:121) of the investigational drug Acelarin in combination with cisplatin for...[ Price : $8.95]
Federal Register notice: FDA classifies orthopedic surgical instrumentation designed for osteochondral implants with press-fit fix...[ Price : $8.95]
Federal Register notice: FDA makes available a revised draft guidance entitled Drug Products Labeled as Homeopathic.[ Price : $8.95]
Federal Register notice: FDA withdraws the NDA approval of Allergan Pharmaceuticals Lo Minastrin FE because it is no longer market...[ Price : $8.95]
Federal Register notice: FDA classifies internal therapeutic massagers into Class 2 (special controls).[ Price : $8.95]
FDA grows concerned over recent closures of certain large-scale sterilization facilities that use ethylene oxide to sterilize medi...